Related Experiment Videos

Impact of comorbidities on mortality in hospitalized patients with COVID-19: An experience from Iran

Firooz Toofan1, Seyed Mojtaba Hosseini1, Khalil Alimohammadzadeh1,2

  • 1Department of Health Services Management, North Tehran Branch, Islamic Azad University, Tehran, Iran.

Insights

Patients with pre-existing chronic conditions face a higher risk of death from COVID-19. Multimorbidity significantly increases in-hospital mortality risk for COVID-19 patients.

Area of Science:

  • Epidemiology
  • Infectious Diseases
  • Public Health

Background:

  • The COVID-19 pandemic's global impact necessitates understanding clinical characteristics and prognostic factors.
  • Limited information exists on how pre-existing conditions influence COVID-19 outcomes.

Purpose of the Study:

  • To investigate the impact of pre-existing chronic comorbid conditions and multimorbidity on mortality risk in COVID-19 patients.

Main Methods:

  • Retrospective, cross-sectional, observational, single-center study.
  • Analysis of 2597 hospitalized COVID-19 patients from February to September 2020.
  • Multivariate logistic regression to assess independent effects of pre-existing conditions.

Main Results:

  • 36.5% of patients had at least one pre-existing condition.
  • Older age, male sex, diabetes, cardiovascular disease, hypertension, cancer, chronic kidney disease, liver disease, and COPD were associated with increased mortality.
  • Increased number of comorbidities correlated with higher odds of mortality.

Conclusions:

  • Pre-existing comorbidities significantly increase the risk of in-hospital mortality in COVID-19 patients.
  • Identifying and managing comorbidities is crucial for improving COVID-19 patient outcomes.
Abstract

Related Concept Videos